Mathias Loberg Haarhaus

Mathias Loberg Haarhaus

Affiliated to Research
Visiting address: Baxter Novum, Hälsovägen 7, plan 5, 14186 Stockholm
Postal address: H9 Klinisk vetenskap, intervention och teknik, H9 CLINTEC Med njursjukdomar, 141 52 Huddinge

About me

  • I am a clinical specialist in nephrology and internal medicine and researcher with more than 20 years experience in patient care and translational research, specialized on disturbances in bone and mineral balance, CKD-associated osteporosis, cardiovascular complications, bone turnover markers in CKD, and hemodialysis treatment. I currently work at Diaverum Sweden as Medical Director and at Karolinska University Hospital as consultant, co-heading a multidisciplinary expert group  for managing CKD-associated osteoporosis and other CKD-MBD-associated complications. I am affiliated with Karolinska Institutet, CLINTEC, since 2006, previously affiliated with Linköping University, where I gained my PhD in 2014 with prof. Per Magnusson, clinical chemistry, as supervisor.

    Since 2020 I am board member of the European Renal Association CKD-MBD Working Group whose chairman I was beteween 2022 and 2025. I am also founding member of the European Renal Osteodystrophy (EUROD) Initiative of the European Renal Association, whose mission is to build a European bone biopsy registry and organize research and education in the field of CKD-associated osteoporosis. In Sweden, I am member of the Swedish Nephrological Society's Guidelines Committee and adjunct at the Regional Program Group for Nephrology (RPO Stockholm-Gotland). As key opinion leader within the field of CKD-associated osteoporosis, I have co-authored several international consensus papers, offering clinical guidance in areas where evidence is not sufficient for formal guidelines. I also was an invited member at the Kidney Disease - Improving Global Outcomes 2023 CKD-MBD Controversies Conference.

    In addition to the European EUROD Research Network and the Eropean Renal Association CKD-MBD Working Group, I participate in the KaroKidney research network at Karolinska Institutet, aiming at improving health outcomes in kidney disease, in an international research group exploring skeletal- and systemic effects of ADPKD, in a Swedish collaboration with KTH, exploring the effect of blood flow modulation on dialysis blood access, and in a collaboration with Linköping University to explore the role of alkaline phosphatase in the pathomechanism of and as treatment target for pathologic mineralization. I have supervised several MD masters thesis and co-supervised 2 PhD students, have organised several CME courses and give lectures in graduate and post-graduate education. I have acted as Country PI and PI in several multicenter clinical trials in collaboration with pharmacological industry.

Articles

All other publications

Grants

  • A study of operated blood vessels used for dialysis – assessment of prospective factors for the occurrence of vascular stenosis through ultrasound examination and computer-based blood flow simulations
    Stiftelsen för njursjuka
    1 January 2025 - 31 December 2025
    Ca 6% av den svenska befolkningen har kronisk njursvikt (CKD) (Stendahl 2017). Av dessa har ca 4000 patienter en så kallade terminal njursvikt och ca 3000 patienter är beroende på hemodialys (Svenskt njurregister 2023), 70% av dessa dialyseras via en arteriovenös fistel (AVF). Varje år skapas 900 fistlar via kirurgi, 30% av nyanlagda fistlar kräver åtgärd innan de fungerar, ännu fler utvecklar kärlstenoser när fisteln har börjat användas. Detta äventyrar dialyskvalitén och försämrar prognosen. Syftet med studien är att identifiera riskfaktorer för stenosering i AVF. Detta arbete är ett tvärvetenskapligt projekt där den kliniska studien kombineras och sker parallellt med tekniska studier (KTH Teknisk mekanik) där numeriska strömningsberäkningar (computational fluid dynamics, CFD) kommer att genomföras på geometrier skapade från ultraljudsmätningar utförda på patient. Vi kommer kunna identifiera patientprofiler och anatomiska/fysiologiska förhållanden med högre eller lägre risk för AVF-komplikationer. Då blodaccessen har en direkt påverkan på dialyskvalitén kommer resultaten av vår forskning även ha betydelse för sjuklighet och överlevnad av hemodialyspatienter. Resultaten från denna studie har betydelse för kliniska beslut avseende anläggning och revidering av AV-fistlar samt utformning av dialysordinationer. Dessutom kommer våra resultat kunna bilda ett underlag för optimering av den redan pågående utvecklingen av artificiell intelligens-baserade algoritmer för AVF övervakning och prognos.
  • Chronic kidney disease – a clinical model of premature vascular ageing
    Hjärt-Lungfonden
    1 January 2017 - 31 December 2019

News from KI

Events from KI